Stay updated on Lintuzumab-Ac225 in Older AML Patients Clinical Trial

Sign up to get notified when there's something new on the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Significant: there is an updated operating-status notice and a new version (v3.2.0) replacing v3.1.0. This informs users about potential delays, open status of NIH Clinical Center, and directs to cc.nih.gov and opm.gov for updates.
    Difference
    3%
    Check dated 2025-10-06T04:25:53.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Upgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T01:00:47.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.
    Difference
    0.2%
    Check dated 2025-09-14T18:45:22.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, and a 'Back to Top' feature has been added.
    Difference
    0.2%
    Check dated 2025-09-07T13:11:23.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, along with a comprehensive list of drug information, particularly various chemical compounds and medications. However, many specific medical topics and related resources have been removed.
    Difference
    5%
    Check dated 2025-08-31T05:46:25.000Z thumbnail image
  9. Check
    70 days ago
    Change Detected
    Summary
    The web page now includes information about a Phase I trial of alpha-particle immunotherapy involving 225Ac-lintuzumab and low-dose cytarabine for patients aged 60 or older with untreated acute myeloid leukemia.
    Difference
    1%
    Check dated 2025-08-24T03:11:42.000Z thumbnail image

Stay in the know with updates to Lintuzumab-Ac225 in Older AML Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page.